Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
40.06
+1.15 (2.96%)
At close: Jun 26, 2026, 4:00 PM EDT
40.06
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Rapport Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Rapport Therapeutics stock have an average target of 53.56, with a low estimate of 40 and a high estimate of 66. The average target predicts an increase of 33.70% from the current stock price of 40.06.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Rapport Therapeutics stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 10 | 10 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $52 | Buy | Initiates | $52 | +29.81% | Jun 24, 2026 |
| BTIG | BTIG | Buy Maintains $65 | Buy | Maintains | $65 | +62.26% | Jun 2, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $44 → $56 | Buy | Maintains | $44 → $56 | +39.79% | May 18, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $56 | Buy | Maintains | $56 | +39.79% | May 12, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $50 | Buy | Reiterates | $50 | +24.81% | May 7, 2026 |
Financial Forecast
Revenue This Year
20.00M
Revenue Next Year
n/a
from 20.00M
Decreased by -100.00%
EPS This Year
-3.47
from -2.86
EPS Next Year
-4.47
from -3.47
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.0M | n/a | |
| Avg | 20.0M | n/a | |
| Low | 20.0M | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | -100.0% | - |
| Avg | -100.0% | - |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.00 | -3.56 | |
| Avg | -3.47 | -4.47 | |
| Low | -3.67 | -5.89 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.